Bill

Bill > A1830


NJ A1830

Establishes protection from adverse employment action for authorized medical cannabis patients.


summary

Introduced
01/11/2022
In Committee
01/11/2022
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

This bill would establish protections from adverse employment actions for registered patients using medical cannabis pursuant to the "Jake Honig Compassionate Use Medical Cannabis Act." Specifically, an employer would be prohibited from taking any adverse employment action against an employee based on the employee's status as a registry identification cardholder or based on a positive test for cannabis, unless the employer establishes by a preponderance of the evidence that the lawful use of medical cannabis has impaired the employee's ability to perform the employee's job responsibilities. The bill provides that an employer may consider an employee's ability to perform the employee's job responsibilities to be impaired when the employee manifests specific articulable symptoms while working that decrease or lessen the employee's performance of the duties or tasks of the employee's job position. If an employer has a drug testing policy and an employee or job applicant tests positive for cannabis, the employee or job applicant is to be offered an opportunity to present a legitimate medical explanation for the positive test result, and is to be provided written notice of the right to explain. Within three working days after receiving notice, the employee or job applicant would be permitted to submit information to the employer to explain the positive test result, or request a confirmatory retest of the original sample at the employee's or job applicant's own expense. An employee or job applicant would be permitted to present a health care practitioner's recommendation for medical cannabis, a registry identification card, or both, as part of the employee's or job applicant's explanation for the positive test. Nothing in the bill would restrict an employer's ability to prohibit or take adverse employment action for the possession or use of intoxicating substances during work hours, or require an employer to commit any act that would cause the employer to be in violation of federal law, or that would result in the loss of a federal contract or federal funding. The bill defines "adverse employment action" to mean refusing to hire or employ a qualified registered patient, barring or discharging a qualified registered patient from employment, requiring a qualified registered patient to retire from employment, or discriminating against a qualified registered patient in compensation or in terms, conditions, or privileges of employment.

AI Summary

This bill establishes protections from adverse employment actions for registered patients using medical cannabis under the "Jake Honig Compassionate Use Medical Cannabis Act." Employers are prohibited from taking adverse employment actions against employees based solely on their status as a medical cannabis registry cardholder or a positive test for cannabis, unless the employer can prove the employee's cannabis use has impaired their job performance. The bill allows employers to consider an employee's performance as impaired if they exhibit specific symptoms that affect their job duties. If an employee tests positive, they must be given an opportunity to provide a legitimate medical explanation or request a confirmatory retest. The bill does not restrict an employer's ability to prohibit or take action for intoxication during work hours or require an employer to violate federal law. The term "adverse employment action" is defined to include refusing to hire, terminating, or discriminating against qualified registered medical cannabis patients.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced, Referred to Assembly Health Committee (on 01/11/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...